1. Lawsuit-ridden J&J tumbles in annual listing of best global brands — AstraZeneca gets Q2 2020 PDUFA date for breast cancer ADC — Shionogi's antibiotic clears FDA panel vote — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Ozanimod

Discussion in 'Celgene' started by anonymous, Aug 23, 2019 at 1:59 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    This division has no future at all- look at Mayzent sales performance and this drug will get about half of what that is getting. This drug is dead before launch. Run unless you are unemployed.
     
  2. anonymous

    anonymous Guest

    This drug (ozanimod) has about a 50% chance of getting approved by the FDA and a 2% chance of a neurologist ever using it. Unless you are unemployed, you really don't want to be a part of this.
     
  3. anonymous

    anonymous Guest

    What is laughable is everything That is being said about the lack of success of this product is exactly what everyone said about Otezla! When reading the boards after I got the job with Celgene to launch Otezla I started to freak out thinking oh my gosh what have I done and then look at turns out to be a massive billion dollar Blockbuster. Don’t listen to all these fools- they don’t know!!
     
  4. anonymous

    anonymous Guest

    Sounds like you're using Trump logic and data. Maybe throw in a couple of "many people have said" and "we'll see what happens" and you sound like an even bigger moron.
     
  5. anonymous

    anonymous Guest

    BAHAHAHAHAHAHAHAHAHAHAHAHAHA KEEP SMOKING YOUR WEED AND BELIEVING THIS
     
  6. anonymous

    anonymous Guest


    What you are leaving out is that Otezla, a placebo, had Ron (with Scott's protection) to create a performance based culture that sold this water pill. Sold it like a boss.

    Ron ain't around anymore and the metrics driven approach will not work with the 25th product on the market.
     
  7. anonymous

    anonymous Guest


    Truth! Mark Alles can thank everyone else all day long and never give credit to sales, but Ron's system is what made Otezla a winner.
     
  8. anonymous

    anonymous Guest

    Well good news- cux Ozanomid works as well as placebo and will cost 5x more than generic Gilenya. Good luck selling this POS. It's a crowded market and this is not a standout drug.
     
  9. anonymous

    anonymous Guest

    Beware of the East Regional- you have been warned. And CW in the west has no clue about what he's doing either. Just sayin
     
  10. anonymous

    anonymous Guest

    Any decent offers made yet??? I am in the final 2 but honestly don't know still if I will take this job if offered. Boils down to cash- given the high uncertainty whether this drug will even get approved or not or whether the safety is actually better than Gilenya/Mayzent.
     
  11. anonymous

    anonymous Guest

    Who cares? This drug is dead before it even launches (I mean IF it even launches). Those joining this team will be unemployed within a year after launch. Payers will favor generic Gilenya all day long. Your 5-10 years late to the party people.
     
  12. anonymous

    anonymous Guest

    Can anyone tell me why the East regional was fired from Novartis? Curious minds want to know. Does SL know about this? She is proving to be a bimbo.
     
  13. anonymous

    anonymous Guest

    SL should be fired for hiring two highly incompetent Regionals. One was fired from Novartis and the other isn't qualified to be a primary care DM for Merck or Pfizer?
     
  14. anonymous

    anonymous Guest

    is the Novartis fired person JT?
     
  15. anonymous

    anonymous Guest

    ding ding!
     
  16. anonymous

    anonymous Guest

    JR- Romano
     
  17. anonymous

    anonymous Guest

    CW needs a shave and a bath- stinks like a rotting catfish
     
  18. anonymous

    anonymous Guest

    Wait?! Both Jason’s were fired from Novartis? Which - JR or JT is at Novartis?
     
  19. anonymous

    anonymous Guest

    Romano is an idiot. He completely fucked up the HUB for gilenya
     
  20. anonymous

    anonymous Guest


    he was abandoned by Todd but he is sticking to his story that he will soon be running all of Nuero

    very arrogant, just glad he doesn't live up here and prefers to work from his Southern hideout.

    I'm amazed they put this guy in place because I know who they turned down to take him.